Titan Pharmaceuticals Inc (TTNP)
6.71
+0.01
(+0.15%)
USD |
NASDAQ |
May 02, 16:00
6.71
0.00 (0.00%)
After-Hours: 17:21
Titan Pharmaceuticals Cash from Operations (Quarterly): -2.246M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.246M |
| September 30, 2023 | -1.835M |
| June 30, 2023 | -1.112M |
| March 31, 2023 | -1.899M |
| December 31, 2022 | -1.579M |
| September 30, 2022 | -1.873M |
| June 30, 2022 | -1.767M |
| March 31, 2022 | -2.964M |
| December 31, 2021 | -1.081M |
| September 30, 2021 | -2.262M |
| June 30, 2021 | -1.931M |
| March 31, 2021 | -2.625M |
| December 31, 2020 | -4.561M |
| September 30, 2020 | -3.447M |
| June 30, 2020 | -3.983M |
| March 31, 2020 | -5.212M |
| December 31, 2019 | -3.663M |
| September 30, 2019 | -3.325M |
| June 30, 2019 | -4.149M |
| March 31, 2019 | -4.308M |
| December 31, 2018 | -3.308M |
| September 30, 2018 | -2.268M |
| June 30, 2018 | -1.856M |
| March 31, 2018 | -0.999M |
| December 31, 2017 | -3.863M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.545M |
| June 30, 2017 | -2.52M |
| March 31, 2017 | -3.11M |
| December 31, 2016 | -2.408M |
| September 30, 2016 | -2.768M |
| June 30, 2016 | 13.51M |
| March 31, 2016 | -2.038M |
| December 31, 2015 | -1.756M |
| September 30, 2015 | -1.762M |
| June 30, 2015 | -1.922M |
| March 31, 2015 | -2.026M |
| December 31, 2014 | -1.572M |
| September 30, 2014 | -1.395M |
| June 30, 2014 | -1.341M |
| March 31, 2014 | -1.557M |
| December 31, 2013 | -2.104M |
| September 30, 2013 | -2.179M |
| June 30, 2013 | -3.812M |
| March 31, 2013 | -1.704M |
| December 31, 2012 | 9.396M |
| September 30, 2012 | -2.377M |
| June 30, 2012 | -2.657M |
| March 31, 2012 | -2.532M |
| December 31, 2011 | -2.188M |
| September 30, 2011 | -3.32M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.212M
Minimum
Mar 2020
-1.081M
Maximum
Dec 2021
-2.711M
Average
-2.262M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Outset Medical Inc | -24.44M |
| Allurion Technologies Inc | -20.87M |
| AIM ImmunoTech Inc | -9.758M |
| Protalix BioTherapeutics Inc | 3.595M |
| Armata Pharmaceuticals Inc | -8.106M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.504M |
| Cash from Financing (Quarterly) | 0.406M |
| Free Cash Flow | -7.092M |
| Free Cash Flow Per Share (Quarterly) | -2.972 |
| Free Cash Flow Yield | -140.5% |